Clinical Trial Update: The Role of Tofacitinib in Steroid Withdrawal in Rheumatoid Arthritis [Phase 4]

View source ↗

Summary

Phase 4 trial investigating the role of tofacitinib in enabling steroid withdrawal for rheumatoid arthritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Tofacitinib (tofacitinib)

Snippet

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University | Conditions: Rheumatoid Arthritis | Phase 4 | Status: UNKNOWN